Abstract Prolyl hydroxylase domain 3 (PHD3) is a hypoxia inducible factor-α (HIFα) regulator; it degrades HIFα in the presence of oxygen. Recently, there have been an increasing number of studies about the role of PHD3 in proliferation and apoptosis of cancer cells. However, most of the evidence for the role of PHD3 is observational, and little is known of the molecular mechanism. In our current study, we constructed a recombinant eukaryotic expression vector containing the PHD3 gene and detected its biological activity in human hepatoma cell line (HepG2 cells). We successfully constructed a recombinant pcDNA 3.1(+)-PHD3 plasmid; the results showed that PHD3 overexpression could inhibit the proliferation of HepG2 cells and induce apoptosis ...
PHD3, a member of a family of Prolyl-4 Hydroxylase Domain (PHD) proteins, has long been considered a...
AIMS: Tumour hypoxia is associated with an aggressive phenotype and resistance to chemotherapy and r...
SummaryThe success of chemotherapy in cancer treatment is limited by scarce drug delivery to the tum...
PurposeTumour hypoxia activates hypoxia-inducible factor-1 (HIF-1) and indluences angiogenesis, cell...
PurposeTumour hypoxia activates hypoxia-inducible factor-1 (HIF-1) and indluences angiogenesis, cell...
Dept. of Medicine/박사Prolyl hydroxylase domain-containing protein 3 (PHD3) is one of enzymes catalyzi...
Li-rui Tang,1,* Jun-xin Wu,1,* Shao-li Cai,2 Yun-xia Huang,1 Xue-qing Zhang,1 Wan-kai Fu,1 Qing-yang...
In cancer, the response to hypoxia induces dysfunctional and abnormal blood vessels and promotes tum...
Hypoxia restricts cell proliferation and cell cycle progression at the G1/S interface but at least a...
Prolyl hydroxylase domain 2 containing protein (PHD2) is a key protein in regulation of angiogenesis...
<div><p>Prolyl hydroxylase domain 2 containing protein (PHD2) is a key protein in regulation of angi...
Prolyl-4-hydroxylation by the intracellular prolyl-4-hydroxylase enzymes (PHD1-3) serves as a master...
Head and neck squamous cell carcinomas (HNSCC) are sixth most common cancer type in the world. HNSCC...
Abstract Background A key feature of clear cell renal cell carcinoma (ccRCC) is the inactivation of ...
PHD3, a member of a family of Prolyl-4 Hydroxylase Domain (PHD) proteins, has long been considered a...
PHD3, a member of a family of Prolyl-4 Hydroxylase Domain (PHD) proteins, has long been considered a...
AIMS: Tumour hypoxia is associated with an aggressive phenotype and resistance to chemotherapy and r...
SummaryThe success of chemotherapy in cancer treatment is limited by scarce drug delivery to the tum...
PurposeTumour hypoxia activates hypoxia-inducible factor-1 (HIF-1) and indluences angiogenesis, cell...
PurposeTumour hypoxia activates hypoxia-inducible factor-1 (HIF-1) and indluences angiogenesis, cell...
Dept. of Medicine/박사Prolyl hydroxylase domain-containing protein 3 (PHD3) is one of enzymes catalyzi...
Li-rui Tang,1,* Jun-xin Wu,1,* Shao-li Cai,2 Yun-xia Huang,1 Xue-qing Zhang,1 Wan-kai Fu,1 Qing-yang...
In cancer, the response to hypoxia induces dysfunctional and abnormal blood vessels and promotes tum...
Hypoxia restricts cell proliferation and cell cycle progression at the G1/S interface but at least a...
Prolyl hydroxylase domain 2 containing protein (PHD2) is a key protein in regulation of angiogenesis...
<div><p>Prolyl hydroxylase domain 2 containing protein (PHD2) is a key protein in regulation of angi...
Prolyl-4-hydroxylation by the intracellular prolyl-4-hydroxylase enzymes (PHD1-3) serves as a master...
Head and neck squamous cell carcinomas (HNSCC) are sixth most common cancer type in the world. HNSCC...
Abstract Background A key feature of clear cell renal cell carcinoma (ccRCC) is the inactivation of ...
PHD3, a member of a family of Prolyl-4 Hydroxylase Domain (PHD) proteins, has long been considered a...
PHD3, a member of a family of Prolyl-4 Hydroxylase Domain (PHD) proteins, has long been considered a...
AIMS: Tumour hypoxia is associated with an aggressive phenotype and resistance to chemotherapy and r...
SummaryThe success of chemotherapy in cancer treatment is limited by scarce drug delivery to the tum...